Zenith Capital Corp. (ZHCLF)
Develops cancer-fighting drugs through epigenetic research partnerships.
$0.05+0.00%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago+400.0%
The outlook
ZHCLF is trading near the lower end of its 52-week range, well below both its 50- and 200-day moving averages. Current analyst coverage appears thin, and the overall sentiment leans bearish based on available data. The stock is positioned in a weak technical setup relative to recent trends.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range26% of the way from its 52-week low to high
Market cap
$8.0M
52-wk high
$0.19
52-wk low
$0.00
50-day avg
$0.06
200-day avg
$0.07
Trailing P/E
—